![]() |
|
|
RESÚMENES OCTUBRE 2009 |
Other Neuropsychiatric
Disorders & General Information
(Haga un click en la
información del journal
para acceder al resúmen)
5
– doble-ciego o
metanálisis; 4 – subanálisis o simple ciego; 3
– revisión, abierto, básico; 2 –
casos; 1 – opinión
GRATIS = Texto
gratuito en algunos países de la región iberoamericana
3! - Maternal tobacco, cannabis and
alcohol use during pregnancy and risk of adolescent psychotic symptoms in
offspring
Stanley Zammit, Kate Thomas, Andrew
Thompson, Jeremy Horwood, Paulo Menezes, David Gunnell, Chris Hollis, Dieter
Wolke, Glyn Lewis, and Glynn Harrison
The British
Journal of Psychiatry (2009) 195: 294-300
3! -
Escitalopram and Venlafaxine for the Prophylaxis of Migraine Headache Without
Mood Disorders
Tarlaci, Sultan
Clinical Neuropharmacology: September/October 2009 - Volume 32 - Issue
5 - pp 254-258
3! - Cutaneous Adverse Reactions to Psychotropic Drugs:
Data From a Multicenter Surveillance Program
Christian Lange-Asschenfeldt, Renate Grohmann, Bernhard
Lange-Asschenfeldt, Rolf R. Engel, Eckart Rüther, and Joachim Cordes
J Clin Psychiatry 2009;70(9):1258–1265
3! -
Death from violent causes and economic cycles in Bogota, Colombia: a
time-series study, 1997-2006
Moreno
Montoya, José; Sánchez Pedraza, Ricardo
3! - Mortality and cause of
death among psychiatric patients: a 20-year case-register study in an area with
a community-based system of care
L. Grigoletti, G. Perini, A.
Rossi, A. Biggeri, C. Barbui, M. Tansella and F. Amaddeo
Psychological Medicine
(2009), 39:1875-1884 (2009), 39:1875-1884
3 - Applied psychometrics in clinical psychiatry: the pharmacopsychometric
triangle
P. Bech
Acta Psychiatrica
Scandinavica. Volume 120 Issue 5, Pages 400 - 409
3! -
Ginseng for Cognitive Function in Alzheimer's Disease: A Systematic
Myeong Soo Lee, Eun Jin Yang,
Jong-In Kim, Edzard Ernst
Journal of Alzheimer's
Disease. Volume 18, Number 2 / 2009: 339-344
3 -
Cerebrospinal Fluid Biomarkers for Alzheimer's Disease
Kaj
Blennow, Henrik Zetterberg
Journal of Alzheimer's
Disease. Volume 18, Number 2 / 2009: 413-417
GRATIS 3! - Common mental disorder and
obesity: insight from four repeat measures over 19 years: prospective Whitehall
II cohort study
Mika Kivimäki, Debbie A Lawlor, Archana
Singh-Manoux, G David Batty,
Jane E Ferrie, Martin J Shipley, Hermann Nabi, Séverine Sabia, Michael G
Marmot, Markus Jokela
GRATIS 3! -
Drugs Associated with More Suicidal Ideations Are also Associated with More
Suicide Attempts
Robertson HT, Allison DB
5< - Nortriptyline and gabapentin, alone and in combination for neuropathic
pain: a double-blind, randomised controlled crossover trial
Ian
Gilron, Joan M Bailey, Dongsheng Tu, Ronald R Holden, Alan C Jackson and Robyn
L Houlden
The Lancet 2009, Vol 371; Issue 9697: 1252-1261
3! - Correlates of cruelty to animals in the United States: Results from the
National Epidemiologic Survey on Alcohol and Related Conditions
Michael
G. Vaughn, Qiang Fu, Matt DeLisi, Kevin M. Beaver, Brian E. Perron, Katie
Terrell and Matthew O. Howard
Journal of Psychiatric Research. Volume 43, Issue 15, October 2009,
Pages 1213-1218
3 -
Effectiveness of Safety Warnings in Atypical Antipsychotic Drugs: An
Interrupted Time-Series Analysis in Spain
Sanfélix-Gimeno, Gabriel;
Cervera-Casino, Pedro; Peiró, Salvador; López-Valcarcel, Beatriz González;
Blázquez, Amparo; Barbera, Teresa
Drug Safety: 1 November 2009 - Volume 32 - Issue 11 - pp 1075-1087
3 -
Management of agitation and aggression associated with Alzheimer's disease:
controversies and possible solutions
Ballard, Clive; Corbett, Anne;
Chitramohan, Ramilgan; Aarsland, Das
Current Opinion in Psychiatry: November 2009 - Volume 22 - Issue 6 - p
532-540
3 -
Psychotropic Medications and the Treatment of Human Prion Diseases
Appleby, Brian S.
CNS & Neurological Disorders - Drug
Targets, Volume 8, Number 5, November 2009 , pp. 353-362(10)
3 - Promising Strategies for
the Prevention of Dementia
Laura E. Middleton,
Kristine Yaffe
Arch Neurol. 2009;66(10):1210-1215
3 - The Clinical Course of Advanced Dementia
Susan
L. Mitchell, Joan M. Teno, Dan K. Kiely, Michele L. Shaffer, Richard N. Jones,
Holly G. Prigerson, Ladislav Volicer, Jane L. Givens, and Mary Beth Hamel
NEJM. Volume 361:1529-1538; October 15,
2009
3! -
Multivariate therapeutic approach to binge-eating disorder: combined
nutritional, psychological and pharmacological treatment
Brambilla, Francesca; Samek,
Lorenzo; Company, Marta; Lovo, Francesca; Cioni, Luisa; Mellado, Carmen
International Clinical Psychopharmacology: November 2009 - Volume 24 -
Issue 6 - pp 312-317
3! -
Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I
Zhou
SF
Clin Pharmacokinet.
2009;48(11):689-723
4 -
What Makes Patients with Fibromyalgia Feel Better? Correlations Between Patient
Global Impression of Improvement and Changes in Clinical Symptoms and Function:
A Pooled Analysis of 4 Randomized Placebo-controlled Trials of Duloxetine
James I. Hudson, Lesley M.
Arnold, Laurence A. Bradley, Ernest H. S. Choy, Philip J. Mease, Fujun Wang,
Jonna Ahl and Madelaine M. Wohlreich
J Rheum. Published
online before print October 15, 2009
3 - Study on the efficacy and tolerability of amisulpride in
medical/surgical inpatients with delirium admitted to a general hospital
L.
Pintor, E. Fuente, E. Bailles and S. Matrai
European Psychiatry. Volume 24, Issue 7, October 2009, Pages 450-455
3 -
Aggressive Behaviour in Adults with Intellectual Disability: Defining the Role
of Drug Treatment
Oliver-Africano, Patricia;
Murphy, Declan; Tyrer, Peter
CNS Drugs: 1 November 2009 - Volume 23 - Issue 11 - pp 903-913
3 -
Adjustment Disorder: Epidemiology, Diagnosis and Treatment
Casey, Patricia
CNS Drugs: 1 November 2009 - Volume 23 - Issue 11 - pp 927-938
3 -
CSF biomarkers predict rate of cognitive decline in Alzheimer disease
3! - Thalamic
deep brain stimulation for treatment-refractory Tourette syndrome
Two-year outcome
M.
Porta, A. Brambilla, A. E. Cavanna, D. Servello, M. Sassi, H. Rickards, and M.
M. Robertson
3 - The effect of oral lipids and circulating
lipoproteins on the metabolism of drugs
Jigar P Patel
Expert Opinion on Drug Metabolism &
Toxicology. November 2009, Vol. 5, No. 11, Pages 1385-1398
3 -
Use of
Antidepressants for Management of Hot Flashes
Pharmacotherapy. Volume: 29 | Issue: 11: 1357-1374
GRATIS 3 -
Critical appraisal of the long-term impact of memantine in treatment of
moderate to severe Alzheimer’s disease
Umamon Puangthong, Ging-Yuek
Robin Hsiung
Neuropsychiatric Disease
and Treatment. Published Date October 2009
GRATIS 3 - On the debate of original
drug versus generic drug
M Çetin, F Arıcıoğlu
Klinik Psikofarmakoloji Bülteni Volume 19, Number 3, 2009
GRATIS 3! - Comorbidity in Adults With
Attention-Deficit Hyperactivity Disorder
Lucy
Cumyn, Lisa French, Lily Hechtman
Can J Psychiatry. 2009;54(10):673–683
3 - Body Dysmorphic Disorder: A Review of Current Nosological Issues and
Associated Cognitive Deficits
Wei Lin Toh, Susan L. Rossell, David J. Castle
Current Psychiatry Reviews. Volume 5 Issue
4: 261-270
GRATIS (previo
registro) 3! - Transcranial Magnetic
Stimulation in the Treatment of Psychiatric Disorders
Current Psychiatry Reports 2009, 11: (6)
447-452
GRATIS 3 - Premenstrual Syndrome and
Premenstrual Dysphoric Disorder: Symptoms and Cluster Influences
Faustino R. Perez-Lopez, Peter Chedraui, Gonzalo
Perez-Roncero, Maria T. Lopez-Baena, Jose L. Cuadros-Lopez
The Open Psychiatry Journal. Volume 3: 39-49
GRATIS 3 - International guide to prescribing psychotropic medication for the
management of problem behaviours in adults with intellectual disabilities
SHOUMITRO
DEB, HENRY KWOK, MARCO BERTELLI, LUIS SALVADOR-CARULLA, ELSPETH BRADLEY, JENNIFER TORR, and JARRET BARNHILL, FOR
THE GUIDELINE DEVELOPMENT GROUP OF THE WPA SECTION ON PSYCHIATRY OF
INTELLECTUAL DISABILITY
World Psychiatry. 2009 October; 8(3):
181–186
| Regresar a RESÚMENES OCTUBRE 2009 |
© 1999-2009 Jorge M
Tamayo, MD, BMSS
Creada en Enero 1999
Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.